Kopin Corporation — FY2021 Form 10-K
Business context and reporting period
Kopin develops and sells high-resolution microdisplays, display subassemblies, optics and related components for defense, industrial, enterprise and consumer applications, and earns revenue from customer-funded development contracts and IP licenses. This is an annual report for the 52-week fiscal year ended December 25, 2021; it does not provide a separate Q4 financial-results breakdown.
Key financial metrics
| Metric | FY2021 | FY2020 |
|---|---|---|
| Total revenue | $45.7 million | $40.1 million |
| Net loss attributable to Kopin | $13.4 million; $0.15 per share | $4.4 million; $0.05 per share |
| Net cash used in operating activities | $10.7 million | $4.4 million |
| Cash, cash equivalents and marketable securities | $29.3 million | $20.7 million |
| Working capital | $34.7 million | $22.6 million |
- Revenue increased 14%. Product revenue was $29.9 million, up from $28.5 million; R&D revenue rose to $14.7 million from $10.1 million. License and other revenue declined to $1.1 million from $1.5 million.
- Loss from operations widened to $13.8 million from $4.8 million. Product cost was 83.8% of net product revenue, implying a 16.2% product gross margin, versus 75.0% cost and 25.0% margin in FY2020.
- Operating expenses increased to $59.4 million from $44.9 million. SG&A rose to $18.1 million from $11.8 million, including higher stock-based compensation, compensation and benefits, and bad-debt expense.
- Cash provided by financing was $20.4 million, principally from equity sales. The company reported no off-balance-sheet arrangements and no material borrowings in the supplied balance sheet; operating lease liabilities totaled $3.8 million.
Material changes versus FY2020
- Defense application revenue decreased to $18.2 million from $20.2 million, mainly on lower shipments to the Joint Strike Fighter program and training and simulation programs.
- Industrial/enterprise revenue rose to $9.7 million from $6.9 million, driven by 3D metrology and industrial headset demand. Consumer revenue increased to $1.9 million from $0.9 million, primarily due to OLED demand.
- Higher funded and internal R&D spending—total R&D expense was $16.3 million versus $11.7 million—alongside lower defense product shipments and higher product costs contributed to the larger operating loss.
- Cash and marketable securities increased despite operating cash outflow, principally because of common-stock sales. The company sold approximately 3.1 million shares for about $21 million net during 2021 and had $44.3 million of capacity remaining under its current ATM agreement at year-end.
Outlook, risks and contingencies
- Management estimated liquidity would fund operations at least through Q1 2023, while stating it expected negative operating cash flow in FY2022. It may seek additional capital, reduce expenses or pursue a strategic transaction; no assurance was given that these actions would be available on acceptable terms.
- Management expects defense production programs to increase over the next several years, but orders depend on program funding, qualification, customer demand and government procurement decisions. Remaining performance obligations were $28.8 million, expected to be recognized over the next 12 months, but government contracts may be cancelled.
- Semiconductor and other component shortages, supplier concentration, foundry capacity and higher input and labor costs threaten production and margins. The filing says identified component shortages could disrupt FY2022 production; replacement components may require customer requalification.
- Two customers, DRS and Collins Aerospace, represented approximately 31% and 30% of FY2021 revenue, respectively. Funded R&D contracts represented 32% of revenue. This concentration, alongside generally cancellable short-term purchase orders, makes revenue less predictable.
- The BlueRadios litigation remains pending. The company said a trial date had not been set, did not consider a loss probable, and recorded no accrual. Management identified significant estimation judgment in cost-to-cost recognition of development-contract revenue; this was also the auditor’s critical audit matter.
- Other material risks include sustained losses and a $319.1 million accumulated deficit, customer and government-program cancellations, competition and OLED commercialization, foreign currency exposure without hedging, and geopolitical, regulatory, cybersecurity and intellectual-property risks. The company reported management’s internal-control assessment as effective; the auditor did not opine on internal control.
Most important facts for investors to verify
- Whether FY2022 component availability, production yields and defense program shipments support the company’s stated production outlook.
- Whether cash burn improves enough to remain within management’s projected liquidity runway, and whether further equity issuance is needed.
- Whether the high customer and contract concentration persists and whether development contracts convert into repeat product orders.
- How R&D contract cost estimates, customer milestones and the $28.8 million remaining-performance-obligation estimate develop, including any cancellations or revisions.
- Developments in the BlueRadios dispute and any resulting financial, patent or operating exposure.